Filing Details
- Accession Number:
- 0000950103-20-020542
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-10-23 19:11:32
- Reporting Period:
- 2020-10-20
- Accepted Time:
- 2020-10-23 19:11:32
- Original Submission Date:
- 2020-10-22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1802768 | Royalty Pharma Plc | RPRX | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1016835 | B Rory Riggs | C/O Royalty Pharma Plc 110 E. 59Th Street New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Disposition | 2020-10-20 | 463,200 | $42.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On October 22, 2020, the Reporting Person filed a Form 4 reporting this sale. This amendment is being filed to report that this sale was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 15,000 Class A Ordinary Shares, with the purchase of Class A Ordinary Shares by the Spouse of the Reporting Person on June 18, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory "profit" calculated pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.